Been watching Rigel since the positive RA results. Stock at one stage hit $31 i think. Anyway the company managed to get the secondary priced at $27. Ever since then the price has plummeted with story still intact. To be honest i never really thought that the data justified the price rise but obviously someone did as the secondary pricing would indicate. Is this stock action unusual? TIA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.